Increased hepatic fat content (HFC) is a hallmark of non-alcoholic fatty liver (NAFL) disease, a common condition in liver transplant recipients. Proton MR spectroscopy (1H MRS) and MR imaging-based proton density fat fraction as the only diagnosis modality enable precise non-invasive measurement of HFC and, also, fatty acid profiles in vivo. Using 1H MRS at 3T, we examined 47 liver transplantation candidates and 101 liver graft recipients. A point-resolved spectroscopy sequence was used to calculate the steatosis grade along with the saturated, unsaturated and polyunsaturated fractions of fatty acids in the liver. The steatosis grade measured by MRS was compared with the histological steatosis grade. HFC, represented by fat fraction values, is adept at distinguishing non-alcoholic steatohepatitis (NASH), NAFL and non-steatotic liver transplant patients. Relative hepatic lipid saturation increases while unsaturation decreases in response to increased HFC. Additionally, relative hepatic lipid saturation increases while unsaturation and polyunsaturation both decrease in liver recipients with histologically proven post-transplant NASH or NAFL compared to non-steatotic patients. HFC, measured by in vivo 1H MRS, correlated well with histological results. 1H MRS is a simple and fast method for in vivo analysis of HFC and its composition. It provides non-invasive support for NAFL and NASH diagnoses.

Department of Hepatogastroenterology Institute for Clinical and Experimental Medicine 140 21 Prague Czech Republic

MR Unit Department of Diagnostic and Interventional Radiology Institute for Clinical and Experimental Medicine 140 21 Prague Czech Republic

Zobrazit více v PubMed

Nassir F., Rector R.S., Hammoud G.M., Ibdah J.A. Pathogenesis and Prevention of Hepatic Steatosis. Gastroenterol. Hepatol. 2015;11:167–175. PubMed PMC

Linares I., Hamar M., Selzner N., Selzner M. Steatosis in Liver Transplantation: Current Limitations and Future Strategies. Transplantation. 2019;103:78–90. doi: 10.1097/TP.0000000000002466. PubMed DOI

Benedict M., Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J. Hepatol. 2017;9:715–732. doi: 10.4254/wjh.v9.i16.715. PubMed DOI PMC

Kramer H., Pickhardt P.J., Kliewer M.A., Hernando D., Chen G.H., Zagzebski J.A., Reeder S.B. Accuracy of Liver Fat Quantification with Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison with MR Spectroscopy. AJR Am. J. Roentgenol. 2017;208:92–100. doi: 10.2214/AJR.16.16565. PubMed DOI PMC

Schwenzer N.F., Springer F., Schraml C., Stefan N., Machann J., Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J. Hepatol. 2009;51:433–445. doi: 10.1016/j.jhep.2009.05.023. PubMed DOI

Cheng Y., Zhang K., Chen Y., Chen Y., Li Y., Li Y., Fu K., Feng R. Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by 1H-MRS and Dual-Echo MRI. Nutrients. 2016;8:527. doi: 10.3390/nu8090527. PubMed DOI PMC

Kovar J., Dusilova T., Sedivy P., Bruha R., Gottfriedova H., Pavlikova P., Pitha J., Smid V., Drobny M., Dezortova M., et al. Acute responses of hepatic fat content to consuming fat, glucose and fructose alone and in combination in non-obese non-diabetic individuals with non-alcoholic fatty liver disease. J. Physiol. Pharmacol. 2021;72:1. doi: 10.26402/jpp.2021.1.05. PubMed DOI

Golabi P., Locklear C.T., Austin P., Afdhal S., Byrns M., Gerber L., Younossi Z.M. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review. World J. Gastroenterol. 2016;22:6318–6327. doi: 10.3748/wjg.v22.i27.6318. PubMed DOI PMC

Zheng D., Guo Z., Schroder P.M., Zheng Z., Lu Y., Gu J., He X. Accuracy of MR Imaging and MR Spectroscopy for Detection and Quantification of Hepatic Steatosis in Living Liver Donors: A Meta-Analysis. Radiology. 2017;282:92–102. doi: 10.1148/radiol.2016152571. PubMed DOI

Chiang H.J., Chang W.P., Chiang H.W., Lazo M.Z., Chen T.Y., Ou H.Y., Tsanga L.L.-C., Huanga T.-L., Chenb C.-L., Cheng Y.-F. Magnetic resonance spectroscopy in living-donor liver transplantation. Transplant. Proc. 2016;48:1003–1006. doi: 10.1016/j.transproceed.2015.10.068. PubMed DOI

Krishan S., Jain D., Bathina Y., Kale A., Saraf N., Saigal S., Choudhary N., Baijal S., Soin A. Non-invasive quantification of hepatic steatosis in living. related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy. Clin. Radiol. 2016;71:58–63. doi: 10.1016/j.crad.2015.10.002. PubMed DOI

Satkunasingham J., Nik H.H., Fischer S., Menezes R., Selzner N., Cattral M., Grant D., Jhaveri K. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors? Liver Transpl. 2018;24:470–477. doi: 10.1002/lt.24965. PubMed DOI

Rastogi R., Gupta S., Garg B., Vohra S., Wadhawan M., Rastogi H. Comparative accuracy of CT. dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors. Indian J. Radiol. Imaging. 2016;26:5–14. doi: 10.4103/0971-3026.178281. PubMed DOI PMC

Hajek M., Dezortova M., Wagnerova D., Skoch A., Voska L., Hejlova I., Trunecka P. MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients. Magn. Reson. Mater. Phys. Biol. Med. 2011;24:297–304. doi: 10.1007/s10334-011-0264-9. PubMed DOI

Provencher S.W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14:260–264. doi: 10.1002/nbm.698. PubMed DOI

Johnson N.A., Walton D.W., Sachinwalla T., Thompson C.H., Smith K., Ruell P.A., Stannard S.R., George J. Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology. 2008;47:1513–1523. doi: 10.1002/hep.22220. PubMed DOI

Strobel K., van den Hoff J., Pietzsch J. Localized proton magnetic resonance spectroscopy of lipids in adipose tissue at high spatial resolution in mice in vivo. J. Lipid Res. 2008;49:473–480. doi: 10.1194/jlr.D700024-JLR200. PubMed DOI

Ren J., Dimitrov I., Sherry A.D., Malloy C.R. Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla. J. Lipid Res. 2008;49:2055–2062. doi: 10.1194/jlr.D800010-JLR200. PubMed DOI PMC

Erickson M.L., Haus J.M., Malin S.K., Flask C.A., McCullough A.J., Kirwan J.P. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype. Nutr. Metab. Cardiovasc. Dis. 2019;29:1197–1204. doi: 10.1016/j.numecd.2019.06.012. PubMed DOI PMC

Traussnigg S., Kienbacher C., Gajdošík M., Valkovič L., Halilbasic E., Stift J., Rechling C., Hofer H., Steindl-Munda P., Ferenci P., et al. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis. Liver Int. 2017;37:1544–1553. doi: 10.1111/liv.13451. PubMed DOI PMC

Gajdošík M., Chadzynski G.L., Hangel G., Mlynárik V., Chmelík M., Valkovič L., Bogner W., Pohmann R., Scheffler K., Trattnig S., et al. Ultrashort-TE stimulated echo acquisition mode (STEAM) improves the quantification of lipids and fatty acid chain unsaturation in the human liver at 7 T. NMR Biomed. 2015;28:1283–1293. doi: 10.1002/nbm.3382. PubMed DOI

Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y., Torbenson M.S., Unalp-Arida A., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321. doi: 10.1002/hep.20701. PubMed DOI

Hejlova I., Honsova E., Sticova E., Lanska V., Hucl T., Spicak J., Jirsa M., Trunecka P. Prevalence and risk factors of steatosis after liver transplantation and patient outcomes. Liver Transpl. 2016;22:644–655. doi: 10.1002/lt.24393. PubMed DOI

Singer P., Gnauck G., Honigmann G., Stolz P., Schliack V., Kettler L.-H., Buntrock P., Thoelke H. The fatty acid pattern of adipose tissue and liver triglycerides according to fat droplet size in liver parenchymal cells of diabetic subjects. Diabetologia. 1974;10:455–458. doi: 10.1007/BF01221637. PubMed DOI

Araya J., Rodrigo R., Videla L.A., Thielemann L., Orellana M., Pettinelli P., Poniachik J. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. 2004;106:635–643. doi: 10.1042/CS20030326. PubMed DOI

Puri P., Baillie R.A., Wiest M.M., Mirshahi F., Choudhury J., Cheung O., Díaz J.C., Signorini C., Sgherri C., Comporti M., et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46:1081–1090. doi: 10.1002/hep.21763. PubMed DOI

Elizondo A., Araya J., Rodrigo R., Poniachik J., Csendes A., Maluenda F., Díaz J.C., Signorini C., Sgherri C., Comporti M., et al. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients. Obesity. 2007;15:24–31. doi: 10.1038/oby.2007.518. PubMed DOI

Yamada K., Mizukoshi E., Sunagozaka H., Arai K., Yamashita T., Takeshita Y., Misu H., Takamura T., Kitamura S., Zen Y., et al. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis. Liver Int. 2015;35:582–590. doi: 10.1111/liv.12685. PubMed DOI

Roumans K.H.M., Lindeboom L., Veeraiah P., Remie C.M.E., Phielix E., Havekes B., Bruls Y., Brouwers M.C.G.J., Ståhlman M., Alssema M., et al. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. Nat. Commun. 2020;11:1891. doi: 10.1038/s41467-020-15684-0. PubMed DOI PMC

Biological Magnetic Resonance Data Bank. [(accessed on 30 June 2021)]. Available online: https://bmrb.io/metabolomics/

Šedivý P., Dezortová M., Burian M., Dusilová T., Kovář J., Hájek M. Comparison of Accuracy of Magnetic Resonance Spectroscopic and Imaging Techniques for the Liver Steatosis Assessment. Chem. Listy. 2021;115:46–53.